Nutrigenomics Market Size, Share, and Analysis, By Product (Reagents and Kits, Services), By Application (Diabetes, Obesity, Gastrointestinal, Woman’s Health, Neurological, Others) and Regional Forecasts, 2022-2032
Nutrigenomics Market Size, Share, and Analysis, By Product (Reagents and Kits, Services), By Application (Diabetes, Obesity, Gastrointestinal, Woman’s Health, Neurological, Others) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Nutrigenomics Market size was USD 0.39 billion in 2021 and projected to grow from USD 0.5 billion in 2023 to USD 2.1 billion by 2032, exhibiting a CAGR of 16.8% during the forecast period.
Nutrigenomics aka nutritional genomics, is the relationship between diet, nutrients, and gene expression. It observes how the consumption of foods by a body can alter the way his genes perform. It also observes how a body’s genes can determine his nutritional needs. Preventing and treating disease rarely holds simply one solution, but nutrigenomics promises to provide a unique future answer.
MARKET HIGHLIGHTS
Nutrigenomics Market is expected to reach USD 2.1 billion, growing at a CAGR of 16.8% during the forecast period owing to speedy adoption of personalized medicine and genomics, rising cases of lifestyle illnesses like obesity and diabetes, and growing awareness for preventative healthcare. Moreover, enhanced disease management on the global scale is expected to boost the growth of Nutrigenomics Market over the forecast period.
Nutrigenomics Market Segments:
Growth Drivers
Rising Cases of Obesity and Growing Importance of Nutritious Food are Expected to Boost the Market Growth
Technological Improvement in Nutrigenomics is Expected to Boost the Market Growth
Restraint
Rising Cost of Treatment and Lack of Skilled Physicians to Restrain the Market Growth
Key Players
PRODUCT OVERVIEW
Nutrigenomics Market size was USD 0.39 billion in 2021 and projected to grow from USD 0.5 billion in 2023 to USD 2.1 billion by 2032, exhibiting a CAGR of 16.8% during the forecast period.
Nutrigenomics aka nutritional genomics, is the relationship between diet, nutrients, and gene expression. It observes how the consumption of foods by a body can alter the way his genes perform. It also observes how a body’s genes can determine his nutritional needs. Preventing and treating disease rarely holds simply one solution, but nutrigenomics promises to provide a unique future answer.
MARKET HIGHLIGHTS
Nutrigenomics Market is expected to reach USD 2.1 billion, growing at a CAGR of 16.8% during the forecast period owing to speedy adoption of personalized medicine and genomics, rising cases of lifestyle illnesses like obesity and diabetes, and growing awareness for preventative healthcare. Moreover, enhanced disease management on the global scale is expected to boost the growth of Nutrigenomics Market over the forecast period.
Nutrigenomics Market Segments:
- Product
- Reagents and Kits
- Services
- Application
- Diabetes
- Obesity
- Gastrointestinal
- Woman’s Health
- Neurological
- Others
Growth Drivers
Rising Cases of Obesity and Growing Importance of Nutritious Food are Expected to Boost the Market Growth
Technological Improvement in Nutrigenomics is Expected to Boost the Market Growth
Restraint
Rising Cost of Treatment and Lack of Skilled Physicians to Restrain the Market Growth
Key Players
- Lifecare Diagnostics
- geneOmbio
- Genova Diagnostics
- Mapmygenome
- Xcode Life
- Metagenics Inc.
- Nutrition Genome
- DNAfit
- GX Sciences Inc.
- Nutrigenomix
- Gini Health
- Cell-Logic
- WellGen Inc.
- Genetic Healing
- SNiP Nutrigenomics
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3. Nutrigenomics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Nutrigenomics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. NUTRIGENOMICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. NUTRIGENOMICS MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Product
10.3.1.1.Reagents and Kits
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Services
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Application
10.3.2.1. Diabetes
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Obesity
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Gastrointestinal
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Woman’s Health
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Neurological
10.3.2.5.1.By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.6.Others
10.3.2.6.1.By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.2. By Application
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Application
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Application
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Application
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Lifecare Diagnostics
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. geneOmbio
17.3. Genova Diagnostics
17.4. Mapmygenome
17.5. Xcode Life
17.6. Metagenics Inc.
17.7. Nutrition Genome
17.8. DNAfit
17.9. GX Sciences Inc.
17.10. Nutrigenomix
17.11.Gini Health
17.12. Cell-Logic
17.13. WellGen Inc.
17.14. Genetic Healing
17.15. SNiP Nutrigenomics
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3. Nutrigenomics Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Nutrigenomics Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. NUTRIGENOMICS MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. MARKET ANALYSIS
8.1. Porters Five Forces
8.2. PEST Analysis
8.2.1. Political
8.2.2.Economic
8.2.3.Social
8.2.4.Technological
9. NUTRIGENOMICS MARKET
9.1. Overview
9.2.Historical Analysis (2016-2021)
9.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
10. NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
10.1.Overview
10.2. Key Findings
10.3. Market Segmentation
10.3.1. By Product
10.3.1.1.Reagents and Kits
10.3.1.1.1.By Value (USD Million) 2022-2032F
10.3.1.1.2. Market Share (%) 2022-2032F
10.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
10.3.1.2. Services
10.3.1.2.1. By Value (USD Million) 2022-2032F
10.3.1.2.2.Market Share (%) 2022-2032F
10.3.1.2.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.By Application
10.3.2.1. Diabetes
10.3.2.1.1. By Value (USD Million) 2022-2032F
10.3.2.1.2.Market Share (%) 2022-2032F
10.3.2.1.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.2.Obesity
10.3.2.2.1.By Value (USD Million) 2022-2032F
10.3.2.2.2. Market Share (%) 2022-2032F
10.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
10.3.2.3.Gastrointestinal
10.3.2.3.1.By Value (USD Million) 2022-2032F
10.3.2.3.2. Market Share (%) 2022-2032F
10.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.4.Woman’s Health
10.3.2.4.1. By Value (USD Million) 2022-2032F
10.3.2.4.2.Market Share (%) 2022-2032F
10.3.2.4.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.5.Neurological
10.3.2.5.1.By Value (USD Million) 2022-2032F
10.3.2.5.2.Market Share (%) 2022-2032F
10.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
10.3.2.6.Others
10.3.2.6.1.By Value (USD Million) 2022-2032F
10.3.2.6.2. Market Share (%) 2022-2032F
10.3.2.6.3. Y-o-Y Growth (%) 2022-2032F
11.NORTH AMERICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Product
11.3.2. By Application
11.4.Country
11.4.1. United States
11.4.2.Canada
12. EUROPE NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product
12.3.2.By Application
12.4. Country
12.4.1.Germany
12.4.2. United Kingdom
12.4.3. France
12.4.4. Italy
12.4.5. Spain
12.4.6. Russia
12.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
13. ASIA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product
13.3.2.By Application
13.4. Country
13.4.1.India
13.4.2. China
13.4.3. South Korea
13.4.4. Japan
13.4.5. Rest of APAC
14. MIDDLE EAST AND AFRICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product
14.3.2.By Application
14.4. Country
14.4.1.Israel
14.4.2. GCC
14.4.3. North Africa
14.4.4. South Africa
14.4.5. Rest of Middle East and Africa
15. LATIN AMERICA NUTRIGENOMICS MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product
15.3.2.By Application
15.4. Country
15.4.1.Mexico
15.4.2. Brazil
15.4.3. Rest of Latin America
16. COMPETITIVE LANDSCAPE
16.1. Company market share, 2021
16.2. Key player overview
16.3. Key stakeholders
17. COMPANY PROFILES
17.1.Lifecare Diagnostics
17.1.1.Company Overview
17.1.2. Financial Overview
17.1.3. Key Product; Analysis
17.1.4.Company Assessment
17.1.4.1.Product Portfolio
17.1.4.2. Key Clients
17.1.4.3. Market Share
17.1.4.4. Recent News & Development (Last 3 Yrs.)
17.1.4.5. Executive Team
17.2. geneOmbio
17.3. Genova Diagnostics
17.4. Mapmygenome
17.5. Xcode Life
17.6. Metagenics Inc.
17.7. Nutrition Genome
17.8. DNAfit
17.9. GX Sciences Inc.
17.10. Nutrigenomix
17.11.Gini Health
17.12. Cell-Logic
17.13. WellGen Inc.
17.14. Genetic Healing
17.15. SNiP Nutrigenomics
17.16. Other Prominent Players
18. APPENDIX
19. CONSULTANT RECOMMENDATION
